Back to results
US 10,441,640 B2Granted
Botulinum neurotoxins with modified light chain specificity and methods for producing same
AssigneeBioMadison, Inc.
InventorsFrancis Mark Dunning, Ward Tucker
Life of this patent
Estimating the term…
Abstract
A protease directed to a non-neuronal SNARE protein is described. The protease is produced by selective mutation of a botulinum neurotoxin light chain, and is characterized utilizing a reporting construct that includes all or part of the non-neuronal SNARE protein. Such a protease has utility in the treatment of diseases associated with hypersecretion, where the hypersecretion is mediated by a non-neuronal SNARE protein.
Claims7
A method of identifying a first protease with substrate specificity for a non-neuronal SNARE protein, comprising:
- providing a first reporting construct comprising a first non-neuronal SNARE protein or a fragment thereof that comprises a protease cleavage site of the first non-neuronal SNARE protein, interposed between a first reporter and a second reporter,
- wherein the first non-neuronal SNARE protein or fragment thereof is dimensioned to provide an energy transfer between the first reporter and the second reporter to generate a first signal;
- providing a library comprising a plurality of proteases each comprising a mutated botulinum toxin light chain peptide, wherein each of the plurality of proteases has a different non-native exosite recognition sequence;
- contacting individual proteases of the library with the first reporting construct;
- and
- characterizing a first signal obtained from the first reporting construct,
- wherein change of the first signal indicates identification of a first protease having substrate specificity for the first non-neuronal SNARE protein.
4 more elements
Dependencies are inferred from the claim text.